Skip to main content
. 2015 Aug 12;4(3):198–208. doi: 10.5501/wjv.v4.i3.198

Table 2.

Pharmacogenetics and highly active antiretroviral therapy response

Polymorphisms Drug response
CYP3A5*1 Increased PIs clearance
CYP2B6 rs3475274, rs28399499 Increased EFV and NVP plasma concentrations
ABCB1 3435C > T Better viral responses to EFV exposure
ABCB1 rs1045642 (3435T > C) CT/CC genotype associated with higher CD4 count in EFV, 3TC, NVP containing regimen

PIs: Protease inhibitors; NVP: Nevirapine; EFV: Efavirenz.